InsiderFlow

GADICKE ANSBERT

AKTS

GADICKE ANSBERT serves as 10% Owner at Aktis Oncology, Inc. (AKTS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$23.95M

Total Sells

18 trades

$11.08M

Net Position

Net Buyer

$12.87M

Companies Traded

3

AKTS, HOWL, CGEM

Active Period

May 2021 – Jan 2026

20 total trades

Most Recent

Buy AKTS

Jan 12, 2026 · $20.03M

GADICKE ANSBERT's Insider Trading at Aktis Oncology, Inc. (AKTS)

Buys

1 · $20.03M

Sells

0 · $0.00

Total Shares Bought

1,112,777

Total Shares Sold

0

AKTS Price Chart
Loading chart...
DateTypeValue
Jan 12, 2026 Buy$20.03M

GADICKE ANSBERT's Insider Trading at Cullinan Therapeutics, Inc. (CGEM)

Buys

0 · $0.00

Sells

8 · $8.85M

Total Shares Bought

0

Total Shares Sold

302,396

CGEM Price Chart
Loading chart...
DateTypeValue
Sep 16, 2021 Sell$103.3K
Sep 14, 2021 Sell$449.2K
Sep 9, 2021 Sell$773.7K
Sep 3, 2021 Sell$1.62M
Aug 31, 2021 Sell$816.4K
Aug 27, 2021 Sell$1.48M
Aug 23, 2021 Sell$3.53M
Aug 11, 2021 Sell$83.0K

GADICKE ANSBERT's Insider Trading at Werewolf Therapeutics, Inc. (HOWL)

Buys

1 · $3.92M

Sells

10 · $2.23M

Total Shares Bought

245,000

Total Shares Sold

1,989,818

HOWL Price Chart
Loading chart...
DateTypeValue
Dec 2, 2025 Sell$183.3K
Nov 26, 2025 Sell$136.9K
Nov 21, 2025 Sell$179.6K
Nov 18, 2025 Sell$147.9K
Nov 13, 2025 Sell$200.7K
Nov 7, 2025 Sell$241.3K
Nov 4, 2025 Sell$295.8K
Oct 30, 2025 Sell$391.6K
Oct 27, 2025 Sell$446.4K
Mar 27, 2025 Sell$9.2K
May 6, 2021 Buy$3.92M